Legal Representation
Attorney
Emily A. Bayton
USPTO Deadlines
Next Deadline
1855 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-03)
Due Date
September 03, 2030
Grace Period Ends
March 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 3, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Sep 3, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 10, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Apr 9, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Mar 22, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Mar 22, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Mar 4, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
Mar 4, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jan 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Nov 14, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 14, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 25, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 6, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Oct 6, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 6, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 6, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 6, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jul 8, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jul 8, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Jul 8, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jun 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 9, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 9, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 25, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 25, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 25, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 24, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 23, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 14, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Providing business advice and information on quality and regulatory developments in the field of specialty pharmaceutical products and services; business consulting services; supplier verification services being business consultation services in the fields of supply chain analysis and regulation compliance; business evaluation to assess standard operating procedure services; business advisory in the field of business process management and improvement; Regulatory submission management, namely, assisting others in preparing and filing submissions forlicensing and registrations in wholesale distribution, third party logistics, controlled and non-controlled pharmaceutical products, durable medical equipment, complimentary drug distribution and pharmacy and manufacturer licensure; business consulting services in the field of organizational change management control and organizational change management system validation
First Use Anywhere:
20220500
First Use in Commerce:
20220500
Class 042
Quality assurance services in the field of specialty pharmaceutical products and services; analysis and evaluation of specialty pharmaceutical products to assure compliance with industry standards; deviation management services, namely, inspection services for detecting, correcting, analyzing, and tracking conditions of specialty pharmaceutical products being quality assurance services: Pharmaceutical product evaluation of non-conforming specialty pharmaceutical products; Product quality evaluation of processes, equipment and computer applications for specialty pharmaceutical products and services; on-site product quality evaluation services
First Use Anywhere:
20220500
First Use in Commerce:
20220500
Class 045
Regulatory compliance advice and consulting services in the field of pharmaceuticals
First Use Anywhere:
20220500
First Use in Commerce:
20220500
Additional Information
Pseudo Mark
QR CARE
Classification
International Classes
035
042
045